معرفی
Sudhin A. Shah, Ph.D., is an Associate Professor of Neuroscience at Weill Cornell Medical College, jointly appointed in the Brain and Mind Research Institute, the Department of Radiology (Neuroscience in Radiology), and the Department of Rehabilitation Medicine. His federally funded program centers on understanding and treating traumatic brain injury (TBI) through multimodal neuroimaging, electrophysiology, and neuromodulation.
Education
- Ph.D., Cornell University, 2010
- M.S., Columbia University, 2005
- B.Sc., Drexel University, 2002
Research Interests
Dr. Shah’s work addresses the full spectrum of TBI consequences—from acute pathophysiology to chronic cognitive and psychiatric sequelae. Using advanced MRI, PET, and high-density EEG, he investigates neural network disruption, glymphatic clearance, inflammatory biomarkers, and the efficacy of targeted neuromodulation such as thalamic deep brain stimulation. His pediatric collaborations extend these questions to developing brains, seeking biomarkers that predict recovery and guide rehabilitation.
Grant Portfolio & Current Projects
- Brain fluid clearance and misfolded protein dynamics following TBI — Co-Principal Investigator, NIA (2023-2028)
- Multi-Modal Imaging of Mechanisms Underlying Impaired Executive Attention After TBI — Principal Investigator, NIH (2017-2022)
- Missing Activity — Co-Principal Investigator, NIH (2017-2024)
External Relationships & Translation
Dr. Shah serves as a paid consultant to Supernus Pharmaceuticals and maintains equity as well as professional services roles with Cognitive Signals INC, ensuring that bench-to-bedside translation of neurotechnology remains a cornerstone of his research agenda.
